| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,668,364 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,668,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,012 |
234,849 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-01-01 |
4 |
D |
$35.95 |
$130,319 |
D/D |
(3,625) |
235,159 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-30 |
4 |
OE |
$6.28 |
$243,455 |
D/D |
27,031 |
235,264 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-31 |
4 |
OE |
$7.39 |
$222,100 |
D/D |
30,000 |
238,233 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,791 |
238,784 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-10 |
4 |
D |
$38.85 |
$87,024 |
D/D |
(2,240) |
239,396 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-01 |
4 |
D |
$35.34 |
$138,992 |
D/D |
(3,933) |
240,168 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-15 |
4 |
AS |
$35.46 |
$107,727 |
D/D |
(3,038) |
240,168 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-15 |
4 |
D |
$38.39 |
$22,074 |
D/D |
(575) |
240,482 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
241,057 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-15 |
4 |
AS |
$40.32 |
$122,532 |
D/D |
(3,039) |
241,254 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,477 |
241,636 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-18 |
4 |
D |
$37.52 |
$23,075 |
D/D |
(615) |
241,645 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,778 |
242,260 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-21 |
4 |
D |
$38.03 |
$22,552 |
D/D |
(593) |
242,765 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
243,206 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,713 |
243,358 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-22 |
4 |
D |
$39.20 |
$25,558 |
D/D |
(652) |
243,996 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,750 |
244,101 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-15 |
4 |
D |
$40.01 |
$23,006 |
D/D |
(575) |
244,293 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,883 |
244,648 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-15 |
4 |
OE |
$0.00 |
$22,519 |
D/D |
4,700 |
244,868 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-28 |
4 |
D |
$38.78 |
$21,872 |
D/D |
(564) |
245,061 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
245,625 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-20 |
4 |
D |
$40.11 |
$319,235 |
D/D |
(7,959) |
252,123 |
0 |
- |
|
176 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
